122 related articles for article (PubMed ID: 27084156)
1. [Resistant hypertension: often the therapy is to blame].
Holzgreve H
MMW Fortschr Med; 2016 Mar; 158(6):44. PubMed ID: 27084156
[No Abstract] [Full Text] [Related]
2. [How to unravel hyperaldosteronism in clinical practice].
van der Giet M
MMW Fortschr Med; 2014 Oct; 156(17):61-2. PubMed ID: 25417478
[No Abstract] [Full Text] [Related]
3. [Spironolactone is the best option in "resistant" hypertension].
Overbeck P
MMW Fortschr Med; 2015 Sep; 157(16):9. PubMed ID: 26783595
[No Abstract] [Full Text] [Related]
4. [Difficult-to-control hypertension: management and evidence].
Vonend O
Dtsch Med Wochenschr; 2014 Nov; 139(48):2463-5. PubMed ID: 25409406
[No Abstract] [Full Text] [Related]
5. [Aldosterone antagonists--first choice in resistant hypertension].
Holzgreve H
MMW Fortschr Med; 2016 Apr; 158(7):65-6. PubMed ID: 27071591
[No Abstract] [Full Text] [Related]
6. Resistant hypertension: medical management and alternative therapies.
Ghofrani H; Weaver FA; Nadim MK
Cardiol Clin; 2015 Feb; 33(1):75-87. PubMed ID: 25439332
[TBL] [Abstract][Full Text] [Related]
7. [Primary hyperaldosteronism. Not an exotic cause of hypertension].
Füessl HS
MMW Fortschr Med; 2006 Nov; 148(45):37, 39-40. PubMed ID: 17615747
[No Abstract] [Full Text] [Related]
8. [Primary hyperaldosteronism--more common than previously thought].
Diderich S; Willenberg HS; Schirpenbach C; Hahner S; Quinkler M
MMW Fortschr Med; 2010 Feb; 152(7):32-5. PubMed ID: 20364506
[No Abstract] [Full Text] [Related]
9. [Treatment refractory hypertension with atrophic kidney: attending to one and not neglecting the other].
Guertler M; Vetter W; Suter PM
Praxis (Bern 1994); 2003 Jan; 92(4):139-42. PubMed ID: 12632844
[TBL] [Abstract][Full Text] [Related]
10. [Resistant hypertension].
Bendersky M
Rev Fac Cien Med Univ Nac Cordoba; 2012; 69(3):156-9. PubMed ID: 23286578
[TBL] [Abstract][Full Text] [Related]
11. [Treatment refractory hypertension. When should an endocrine etiology be considered?].
Stiefelhagen P
MMW Fortschr Med; 2014 Mar; 156 Spec No 1(1):20. PubMed ID: 24930338
[No Abstract] [Full Text] [Related]
12. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
Middeke M
Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
[No Abstract] [Full Text] [Related]
13. Home versus ambulatory blood pressure monitoring in the diagnosis of clinic resistant and true resistant hypertension.
Nasothimiou EG; Tzamouranis D; Roussias LG; Stergiou GS
J Hum Hypertens; 2012 Dec; 26(12):696-700. PubMed ID: 22071448
[TBL] [Abstract][Full Text] [Related]
14. [Primary hyperaldosteronism: boundaries of diagnostics and therapy].
Riester A; Reincke M; Beuschlein F
Dtsch Med Wochenschr; 2014 Oct; 139(40):1982-4. PubMed ID: 25254391
[No Abstract] [Full Text] [Related]
15. Severe and refractory hypertension in a young woman.
Cuadra RH; White WB
J Am Soc Hypertens; 2016 Jun; 10(6):506-9. PubMed ID: 27160032
[TBL] [Abstract][Full Text] [Related]
16. [Resistant hypertension: a case report].
Bruno RM; Ghiadoni L; Mazzi V; Taddei S
Recenti Prog Med; 2010 Jan; 101(1):35-8. PubMed ID: 20391685
[TBL] [Abstract][Full Text] [Related]
17. [Therapy-resistant hypertension--the endocrinological view].
Beuschlein F; Reincke M
MMW Fortschr Med; 2007 Mar; 149(9):29-32. PubMed ID: 17612246
[TBL] [Abstract][Full Text] [Related]
18. Drug adherence monitoring in clinical trials: a necessity for a correct assessment of the efficacy and safety of antihypertensive therapies.
Burnier M; Wuerzner G
J Hypertens; 2015 Dec; 33(12):2395-8. PubMed ID: 26485464
[No Abstract] [Full Text] [Related]
19. [Current hypertension guide lines].
Sökeland J
Urologe A; 2005 Aug; 44(8):929, 931. PubMed ID: 16742006
[No Abstract] [Full Text] [Related]
20. [Hypertension on the move].
Unger T
Dtsch Med Wochenschr; 2014 Nov; 139(48):2439. PubMed ID: 25409399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
